SARAH MINARICK: Open Payments
NPI 1689849754 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 25 payments from 10 companies in 2025. Trend: 2023 $752 · 2024 $519 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $164 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| GENZYME CORPORATION | 2 | $44 |
| ABBVIE INC. | 2 | $42 |
| Galderma Laboratories, L.P. | 2 | $36 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Amgen Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Organon LLC | 1 | $4 |
Products named: TALTZ, SKYRIZI, NEMLUVIO, DUPIXENT, COSENTYX, ILUMYA, Sotyktu, Otezla.
Industry payments across NE — which companies pay providers there.
